ARDS vs GILD: Which Stock is Better?
Side-by-side comparison of Aridis Pharmaceuticals Inc and Gilead Sciences Inc in 2026
ARDS
Aridis Pharmaceuticals Inc
$0.00
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ARDS | GILD | Winner |
|---|---|---|---|
| Market Cap | $0.01M | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | ARDS |
| Gross Margin | 23.3% | 78.7% | GILD |
Analyze ARDS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARDS or GILD a better investment?
Comparing ARDS and GILD: Aridis Pharmaceuticals Inc has a market cap of $0.01M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARDS and GILD?
ARDS (Aridis Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARDS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARDS or GILD?
ARDS has higher revenue growth at 0.0% vs 0.0% for GILD.
Which company is more profitable: ARDS or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 23.3% for ARDS.
Which is the larger company: ARDS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $0.01M for ARDS.
Should I buy ARDS or GILD in 2026?
Both ARDS and GILD have investment merit. ARDS trades at $0.00 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARDS and GILD stock?
Key differences: Market Cap ($0.01M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (23.3% vs 78.7%).